Joanne Curley - Net Worth and Insider Trading

Joanne Curley Net Worth

The estimated net worth of Joanne Curley is at least $1 Million dollars as of 2024-11-13. Joanne Curley is the Chief Development Officer of Vera Therapeutics Inc and owns about 26,962 shares of Vera Therapeutics Inc (VERA) stock worth over $1 Million. Details can be seen in Joanne Curley's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joanne Curley has not made any transactions after 2023-08-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Joanne Curley

To

Joanne Curley Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joanne Curley owns 2 companies in total, including Vistagen Therapeutics Inc (VTGN) , and Vera Therapeutics Inc (VERA) .

Click here to see the complete history of Joanne Curley’s form 4 insider trades.

Insider Ownership Summary of Joanne Curley

Ticker Comapny Transaction Date Type of Owner
VTGN Vistagen Therapeutics Inc 2021-04-23 director
VERA Vera Therapeutics Inc 2023-08-21 Chief Development Officer

Joanne Curley Latest Holdings Summary

Joanne Curley currently owns a total of 1 stock. Joanne Curley owns 26,962 shares of Vera Therapeutics Inc (VERA) as of August 21, 2023, with a value of $1 Million.

Latest Holdings of Joanne Curley

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VERA Vera Therapeutics Inc 2023-08-21 26,962 48.58 1,309,814

Holding Weightings of Joanne Curley


Joanne Curley Form 4 Trading Tracker

According to the SEC Form 4 filings, Joanne Curley has made a total of 18 transactions in Vera Therapeutics Inc (VERA) over the past 5 years, including 0 buys and 18 sells. The most-recent trade in Vera Therapeutics Inc is the sale of 1,490 shares on August 21, 2023, which brought Joanne Curley around $24,823.

Insider Trading History of Joanne Curley

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joanne Curley Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Joanne Curley Ownership Network

Ownership Network List of Joanne Curley

No Data

Ownership Network Relation of Joanne Curley

Insider Network Chart

Joanne Curley Owned Company Details

What does Vistagen Therapeutics Inc do?

Who are the key executives at Vistagen Therapeutics Inc?

Joanne Curley is the director of Vistagen Therapeutics Inc. Other key executives at Vistagen Therapeutics Inc include Chief Operating Officer Joshua S. Prince , CHIEF FINANCIAL OFFICER Cynthia Lynn Anderson , and 10 percent owner Commodore Capital Lp .

Vistagen Therapeutics Inc (VTGN) Insider Trades Summary

Over the past 18 months, Joanne Curley made no insider transaction in Vistagen Therapeutics Inc (VTGN). Other recent insider transactions involving Vistagen Therapeutics Inc (VTGN) include a net purchase of 775,756 shares made by Commodore Capital Lp ,

In summary, during the past 3 months, insiders sold 0 shares of Vistagen Therapeutics Inc (VTGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vistagen Therapeutics Inc (VTGN) were sold and 775,756 shares were bought by its insiders, resulting in a net purchase of 775,756 shares.

Vistagen Therapeutics Inc (VTGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vistagen Therapeutics Inc Insider Transactions

No Available Data

Joanne Curley Mailing Address

Above is the net worth, insider trading, and ownership report for Joanne Curley. You might contact Joanne Curley via mailing address: C/o Vistagen Therapeutics, Inc., 343 Allerton Ave, South San Francisco Ca 94080.